Barclays Upgrades Alvotech to Overweight, Raises Price Target to $8

Barclays analyst Glen Santangelo has upgraded Alvotech (NASDAQ: ALVO) from Underweight to Overweight. The price target for the stock has been raised from $4 to $8.